Dexmedetpmidine Versus Ketamine for Postoperative Sore Throat in Sinus Surgery

Assiut University

Status and phase: Completed; Phase 3

Conditions: Sore Throat

Treatments: Other: saline 0.9%; Drug: Dexmedetomidine; Drug: Ketamine

Study type: Interventional

Funder types: Other

Identifiers

NCT04955158

17101486

Details and patient eligibility

About

The aim of this randomized clinical trial is to evaluate the impact of dexmedetomidine versus ketamine soaked pharyngeal packing on postoperative sore throat in functional endoscopic sinus surgery (FESS).

Full description

A written informed consent was taken from the patients.patients will be randomly assigned to three groups of 40 subjects each; dexmedetomidine or ketamine or saline soaked pharyngeal packs were situated under direct vision. Throat packs made of gauze with a length of 20 cm and a width of 10 cm (folded transverse four times) and medications were diluted with 20 ml normal saline. The packings were placed by the surgeon blinded to the study groups.

1-Dexmedetomidine group: 75 µg dexmedetomidine soaked pharyngeal pack (Group D) putted in the posterior pharyngeal wall after induction of anesthesia and & endotracheal tube (ETT).

2-Ketamine group: 50 mg ketamine soaked pharyngeal pack (Group K) putted in the posterior pharyngeal wall after induction of anesthesia and ETT.

3-Control group: 20 ml 0.9% saline soaked pharyngeal pack (Group C) putted in the posterior pharyngeal wall after induction of anesthesia and ETT.

Enrollment: 143 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults of both sex with American Society of Anesthesiologists (ASA) physical status I-II
• Elective functional endoscopic sinus surgery (FESS) with endotracheal intubation.

Exclusion criteria

• A history of preoperative sore throat.
• Upper respiratory tract illness
• Potentially difficult airway
• Patients with history of neck, respiratory or digestive tract pathology
• Chronic smokers
• Using steroid within the last 48 hour
• Pregnant women

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

143 participants in 3 patient groups

Dexmedetomidine

Experimental group

Description:

75 µg dexmedetomidine soaked pharyngeal pack

Treatment:

Drug: Dexmedetomidine

Ketamine

Experimental group

Description:

50 mg ketamine soaked pharyngeal pack

Treatment:

Drug: Ketamine

Saline placebo

Experimental group

Description:

20 ml 0.9% saline soaked pharyngeal pack

Treatment:

Other: saline 0.9%